Comparing surgical methods for rectal cancer in women
Part of Cancer, Digestive system clinical trials.
This study compares different ways of doing rectal cancer surgery in women to find which approach gives the best recovery and outcomes. It is for women with early-stage rectal cancer that has not spread, and it will help doctors tailor surgery to improve results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosis of rectal adenocarcinoma (a type of rectal cancer) confirmed by biopsy.
- You are a woman planning to have laparoscopic (keyhole) surgery to remove the rectum.
- Body mass index (BMI) of 30 or lower.
- The tumor is within 10 cm of the anal verge (low rectal area).
- No evidence that the cancer has spread to other organs (like the liver or lungs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This study compares two ways of performing rectal cancer surgery: robotic surgery and a newer technique called TaTME (transanal total mesorectal excision). It aims to see which approach has better outcomes for patients. If you're having surgery for rectal cancer, this trial might help you get access to advanced surgical options.
This trial compares a new surgery method that uses multiple technologies to remove rectal cancer more precisely versus the standard surgery. It is for people with middle or lower rectal cancer that hasn't spread, and it may help improve outcomes after surgery.
This trial compares two types of minimally invasive surgery for middle and low rectal cancer: robot-assisted (using a machine) and laparoscopic (using small incisions). The goal is to see which approach offers better outcomes for patients like you.
This trial compares two surgical approaches to remove rectal cancer tissue while aiming to preserve cure chances. It may help you see which approach fits your tumor location and health situation best.
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
Hear when a new Rectal Cancer Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.